Thailand Medication Assisted Therapy (MAT) Market to 2032
Overview
The Thailand Medication Assisted Therapy (MAT) Market is expected to reach a 120.59 by 2032 and is projected to grow at a CAGR of 11.45% from 2025 to 2032.
Revenue, 2024 ()
68.32
Forecast, 2032 ()
120.59
CAGR, 2024 - 2032
11.45%
Report Coverage
Thailand
Thailand Medication Assisted Therapy (MAT) Market 2018-2032
Thailand Medication Assisted Therapy (MAT) Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 68.32
- Projected Market Size (2032): 120.59
- CAGR (2025-2032): 11.45%
Key Findings of Thailand Medication Assisted Therapy (MAT) Market
- The Thailand Medication Assisted Therapy (MAT) Market was valued at 68.32 in 2024.
- The Thailand Medication Assisted Therapy (MAT) Market is likely to grow at a CAGR of 11.45% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Adults in Population Type Segment accounted for the largest share of the market with a revenue of 64.30
- The fastest growing segment Buprenorphine and Naloxone in Products Segment grew Fastest with a CAGR of 14.06% during the forecast period from 2024 to 2032.
Thailand Medication Assisted Therapy (MAT) Market Scope
Thailand Medication Assisted Therapy (MAT) Market Segmentation & Scope
Products
- Acamprosate
- Disulfarm
- Naloxone
- Metadone
- Buprenorphine
- Naltrexone
- Buprenorphine and Naloxone
Drug Type
- Branded
- Generics
Dosage Form
- Extented Release
- Immediate Release
Route of Administration
- Others
- Parenteral
- Oral
Type
- Therapy
- Medication
Population Type
- Teenage
- Adults
End User
- Others
- Homecare
- Speciality Centers
- Hospitals
- Rehabilitation Clinics
Distribution Channel
- Others
- Online Pharmacy
- Retail Pharmacy
- Direct Tender
- Hospital Pharmacy
Thailand Medication Assisted Therapy (MAT) Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2020 |
| Unit | Revenue in |
| Market Value in 2024 | 68.32 |
| Market Value in 2032 | 120.59 |
| CAGR (2025-2032) | 11.45% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Products,Drug Type,Dosage Form,Route of Administration,Type,Population Type,End User,Distribution Channel |
Regional Insights:
-
Leading Market (2024-2032): Thailand, leading in terms of revenue 68.32 in 2024
- Key Country: Thailand, leading in terms of revenue with value of 68.32 in 2024.
Segments and Scope
-
Thailand Medication Assisted Therapy (MAT) Market to 2032, By Products
- Buprenorphine and Naloxone is the largest segment in Thailand Medication Assisted Therapy (MAT) Market to 2032 with a revenue of 8.70 in the year 2024.
- Buprenorphine and Naloxone is the Fastest growing segment in Thailand Medication Assisted Therapy (MAT) Market to 2032 with a Growth rate of 14.06 % in forecast period 2025-2032.
-
Thailand Medication Assisted Therapy (MAT) Market to 2032, By Drug Type
- Generics is the largest segment in Thailand Medication Assisted Therapy (MAT) Market to 2032 with a revenue of 33.12 in the year 2024.
- Generics is the Fastest growing segment in Thailand Medication Assisted Therapy (MAT) Market to 2032 with a Growth rate of 12.40 % in forecast period 2025-2032.
-
Thailand Medication Assisted Therapy (MAT) Market to 2032, By Dosage Form
- Immediate Release is the largest segment in Thailand Medication Assisted Therapy (MAT) Market to 2032 with a revenue of 21.86 in the year 2024.
- Immediate Release is the Fastest growing segment in Thailand Medication Assisted Therapy (MAT) Market to 2032 with a Growth rate of 12.81 % in forecast period 2025-2032.
-
Thailand Medication Assisted Therapy (MAT) Market to 2032, By Route of Administration
- Oral is the largest segment in Thailand Medication Assisted Therapy (MAT) Market to 2032 with a revenue of 20.84 in the year 2024.
- Oral is the Fastest growing segment in Thailand Medication Assisted Therapy (MAT) Market to 2032 with a Growth rate of 12.95 % in forecast period 2025-2032.
-
Thailand Medication Assisted Therapy (MAT) Market to 2032, By Type
- Medication is the largest segment in Thailand Medication Assisted Therapy (MAT) Market to 2032 with a revenue of 36.59 in the year 2024.
- Medication is the Fastest growing segment in Thailand Medication Assisted Therapy (MAT) Market to 2032 with a Growth rate of 12.21 % in forecast period 2025-2032.
-
Thailand Medication Assisted Therapy (MAT) Market to 2032, By Population Type
- Adults is the largest segment in Thailand Medication Assisted Therapy (MAT) Market to 2032 with a revenue of 64.30 in the year 2024.
- Adults is the Fastest growing segment in Thailand Medication Assisted Therapy (MAT) Market to 2032 with a Growth rate of 11.56 % in forecast period 2025-2032.
-
Thailand Medication Assisted Therapy (MAT) Market to 2032, By End User
- Rehabilitation Clinics is the largest segment in Thailand Medication Assisted Therapy (MAT) Market to 2032 with a revenue of 30.99 in the year 2024.
- Rehabilitation Clinics is the Fastest growing segment in Thailand Medication Assisted Therapy (MAT) Market to 2032 with a Growth rate of 12.54 % in forecast period 2025-2032.
-
Thailand Medication Assisted Therapy (MAT) Market to 2032, By Distribution Channel
- Hospital Pharmacy is the largest segment in Thailand Medication Assisted Therapy (MAT) Market to 2032 with a revenue of 20.39 in the year 2024.
- Hospital Pharmacy is the Fastest growing segment in Thailand Medication Assisted Therapy (MAT) Market to 2032 with a Growth rate of 13.01 % in forecast period 2025-2032.
Thailand Medication Assisted Therapy (MAT) Market Company Share Analysis
| Company Name |
|
||
| Viatris Inc. | |||
| Indivior PLC | |||
| Mallinckrodt | |||
| Sun Pharmaceutical Industries Ltd. | |||
| Teva Pharmaceutical Industries Ltd. | |||
Thailand Medication Assisted Therapy (MAT) Market Geographical Sales Distribution, 2018-2032
Thailand Medication Assisted Therapy (MAT) Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Thailand Medication Assisted Therapy (MAT) Market is segmented based on Segmentation Products,Drug Type,Dosage Form,Route of Administration,Type,Population Type,End User,Distribution Channel.
Thailand Medication Assisted Therapy (MAT) Market was valued at USD 68.32(Revenue in ) in 2020.
Thailand Medication Assisted Therapy (MAT) Market is projected to grow at a CAGR of 11.45% during the forecast period of 2024 to 2032.
The Adults segment is expected to dominate the Thailand Medication Assisted Therapy (MAT) Market, holding a largest market share of 64.30 in 2024
Coming Soon....
Thailand Medication Assisted Therapy (MAT) Market Scope
Thailand Medication Assisted Therapy (MAT) Market Segmentation & Scope
Products
- Acamprosate
- Disulfarm
- Naloxone
- Metadone
- Buprenorphine
- Naltrexone
- Buprenorphine and Naloxone
Drug Type
- Branded
- Generics
Dosage Form
- Extented Release
- Immediate Release
Route of Administration
- Others
- Parenteral
- Oral
Type
- Therapy
- Medication
Population Type
- Teenage
- Adults
End User
- Others
- Homecare
- Speciality Centers
- Hospitals
- Rehabilitation Clinics
Distribution Channel
- Others
- Online Pharmacy
- Retail Pharmacy
- Direct Tender
- Hospital Pharmacy
Frequently Asked Questions
The Thailand Medication Assisted Therapy (MAT) Market is segmented based on Segmentation Products,Drug Type,Dosage Form,Route of Administration,Type,Population Type,End User,Distribution Channel.
Thailand Medication Assisted Therapy (MAT) Market was valued at USD 68.32(Revenue in ) in 2020.
Thailand Medication Assisted Therapy (MAT) Market is projected to grow at a CAGR of 11.45% during the forecast period of 2024 to 2032.
The estimated market value of the Thailand Medication Assisted Therapy (MAT) Market for final year is USD 120.59 ().
Thailand Medication Assisted Therapy (MAT) Market Company Profiling
Frequently Asked Questions
The Thailand Medication Assisted Therapy (MAT) Market is segmented based on Segmentation Products,Drug Type,Dosage Form,Route of Administration,Type,Population Type,End User,Distribution Channel.
Thailand Medication Assisted Therapy (MAT) Market was valued at USD 68.32(Revenue in ) in 2020.
Thailand Medication Assisted Therapy (MAT) Market is projected to grow at a CAGR of 11.45% during the forecast period of 2024 to 2032.
The estimated market value of the Thailand Medication Assisted Therapy (MAT) Market for final year is USD 120.59 ().
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.